New research has found that preschoolers who are in the early, pre-symptomatic stages of type 1 diabetes (T1D) have changes in blood sugar levels well before symptoms appear. We used to think that people developed T1D when they first showed the ‘4T’ symptoms: thirst, tiredness, toilet (increased urination) and thin (weight loss). This is when […]
Nikolas Mirco is 12-year-old West Australian who has been living with type 1 diabetes (T1D) since he was seven years old. He and his mum, Rebecca, joined JDRF Australia’s advocacy program this year, to raise the profile of T1D and advocate for increased research funding for the JDRF Clinical Research Network (CRN). Nikolas and Rebecca […]
A new clinical trial investigating the use of semaglutide for type 1 diabetes (T1D) has launched in Sydney and is actively recruiting. The trial, called REducing Cardiometabolic Risk with SEmaglutide in Type 1 diabetes (The RESET1 study) is looking for adults to test whether semaglutide, a medication currently used to treat type 2 diabetes, can […]
Australian researcher Professor Christoph Hagemeyer from Monash University and colleagues have received over $750,000 to take their innovative new insulin formulation to the next stage of research. In people with type 1 diabetes (T1D), the immune system incorrectly attacks the cells of the pancreas that normally produce insulin, a hormone essential to regulate blood sugar […]
We recently had the pleasure of catching up with John Rynehart, the proud father of a remarkable 14-year-old daughter, Annabelle, who navigates the daily challenges of living with type 1 diabetes (T1D) every day. On 5 August 2024, John and his son Seb are setting off on a bold seven-day trek to Mount Kilimanjaro filled […]
JDRF Australia is pleased to acknowledge the recent report from the Parliamentary Committee of Inquiry into Diabetes, which makes 23 recommendations for improving health outcomes for Australians with all forms of diabetes – including type 1 diabetes (T1D). We were delighted to be on hand when Dr Mike Freelander and his Committee handed down their […]
Dear JDRF Community, We are thrilled to share some exciting news about our flagship fundraiser, One Walk. To maximise our impact and align with exciting new initiatives, we are moving the event from October 2024 to March 2025! This change brings numerous benefits to our community and organisation. By shifting One Walk to March 2025, […]
Screening and monitoring will bring forward diagnoses and make early detection of the condition a reality Type 1 diabetes (T1D) diagnoses could soon be transformed with newly released guidance outlining how to detect and monitor early-stage T1D, before the point of symptom onset. The chronic autoimmune condition is traditionally diagnosed when elevated blood glucose levels […]
A new study has added to the evidence that people develop type 1 diabetes (T1D) at different rates, and that a blood test can predict when this may occur We used to think that people only developed T1D when they showed the ‘4T symptoms’: thirst, tiredness, toilet (increased urination) and thin (weigh loss). And while […]
Three Early to Mid-Career researchers (EMCRs) awarded the Tim Welborn EMCR Fellowship JDRF Australia is happy to announce that three promising researchers will be supported under the Tim Welborn Early-to-Mid Career Research (EMCR) Fellowship for basic research. This award funds the next generation of type 1 diabetes (T1D) researchers to ensure their career development is […]
We recently caught up with Rachael Ferguson, Synxbody CEO and mum to a child with type 1 diabetes (T1D). Synxbody is a podiatry and footcare company, founded by Rachael and her business partner in 2011. They recently entered into partnership with JDRF Australia, with a contribution of $1.00 from every online order to JDRF. You […]
The JDRF Australia Board is today announcing that after 20 years of dedicated leadership, Chief Executive Officer (CEO) Mike Wilson has decided the time is right to retire from his role later this year. The Board is thankful for the significant contribution Mike has made over many years, including making substantial progress for people with […]
Welcome to the next chapter of our story. Over the past few years, we’ve had feedback from the type 1 diabetes (T1D) community and potential supporters about how our organisation, and particularly our name, is perceived. We’ve listened, and we’re very excited to share that JDRF is commencing a global rebrand. As a result, we’ll […]
Managing your supplies, including your prescription items and consumables, is an important part of life with type 1 diabetes (T1D). Here are some pointers to help you stay organised. T1D consumables: have a think about what you need Insulin (you need a prescription) Glucagon (you need a prescription) CGM sensors CGM transmitter Over-patches Infusion sets […]
JDRF Australia and JDRF International have announced over $3m AUD in funding for researchers aiming to improve health outcomes for the type 1 diabetes (T1D) community by making precision medicine possible. Precision medicine has delivered great benefits in other disease areas, such as cancer, and involves treatment that is tailored to a person’s genes, environment, […]
It’s National Volunteer Week and this year’s theme is ‘Something for Everyone’. JDRF Australia was founded by volunteers in 1972, volunteers are at the core of all that we do, and we want to recognise and acknowledge all our volunteers who dedicate their time and effort to help us create a world without type […]
JDRF Australia is today welcoming $6.5 million in funding for the continuation of its Type 1 Diabetes Clinical Research Network (CRN), confirmed in the Albanese Government’s Federal Budget last night. The CRN is a critical vehicle for type 1 diabetes (T1D) research funding in Australia and has been accelerating T1D research advancements in Australia for […]
JDRF Australia has announced a new partnership with SynxBody Australia, an Australian footcare company, in a collaborative move towards enhancing awareness, education and support for Australians living with type 1 Diabetes (T1D). SynxBody specialises in premium, affordable footcare products designed to effectively treat common ailments and enhance comfort for people from all walks of life. […]